Phase II assessment of carboplatin with etoposide and high-dose ifosfamide in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...
Today, February 13, the American Society for Testing and Materials (ASTM) International E1527-21 "Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process" ...
Denteric today announced the commencement of participant recruitment for a Phase I clinical study of its first-in-class therapy for Alzheimer's disease.
Many developers know that performing a Phase I Environmental Site Assessment (ESA) prior to purchasing real property is a smart idea. But what exactly is a Phase I ESA? What protections does it ...
Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that selectively activates therapeutic immune payloads within tumour cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results